Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease

Neurobiology of Disease

Volumn 63, Issue , 2014, Pages 85-91

  Cuesta, Marc ^a,b   Aungier, Juliet ^a   Morton, A Jennifer ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Alzheimer's disease; Bright light therapy; Circadian; Exercise; Sleep

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR THERAPY; CAUSE OF DEATH; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUNTINGTON CHOREA; IN VIVO STUDY; LIGHT DARK CYCLE; MALE; MOUSE; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; SLEEP WALKING; SUPRACHIASMATIC NUCLEUS; TRANSGENIC MOUSE;

ALZHEIMER'S DISEASE; BRIGHT LIGHT THERAPY; CIRCADIAN; EXERCISE; SLEEP;

AGE FACTORS; ANIMALS; BEHAVIOR THERAPY; CHRONOBIOLOGY DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; MALE; MICE; MICE, TRANSGENIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRINUCLEOTIDE REPEATS;

EID: 84890847943     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.11.008     Document Type: Article

References (59)

1. Atkinson G., et al. Exercise as a synchroniser of human circadian rhythms: an update and discussion of the methodological problems. Eur. J. Appl. Physiol. 2007, 99:331-341.
2. Aziz N.A., et al. Weight loss in neurodegenerative disorders. J. Neurol. 2008, 255:1872-1880.
3. Aziz N.A., et al. Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. J. Neurol. 2009, 256:1961-1965.
4. Bates G.P., et al. Huntington's Disease 2002, Oxford UP, Oxford.
5. Bode F.J., et al. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic α2-receptor levels in a transgenic Huntington's disease rat model. Behav. Brain Res. 2009, 205:175-182.
6. Bruguerolle B., Simon N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin. Neuropharmacol. 2002, 25:194-201.
7. Buxton O.M., et al. Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R714-R724.
8. Carek P.J., et al. Exercise for the treatment of depression and anxiety. Int. J. Psychiatry Med. 2011, 41:15-28.
9. Carter R.J., et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 1999, 19:3248-3257.
10. Challet E., et al. Neurogenetics of food anticipation. Eur. J. Neurosci. 2009, 30:1676-1687.
11. Ciamei A., Morton A.J. Rigidity in social and emotional memory in the R6/2 mouse model of Huntington's disease. Neurobiol. Learn. Mem. 2008, 89:533-544.
12. Costa e Silva J.A. Sleep disorders in psychiatry. Metabolism 2006, 55:S40-S44.
13. Cuesta M., et al. Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent. Exp. Neurol. 2008, 210:501-513.
14. Cuesta M., et al. The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease. Neurobiol. Dis. 2012, 45:145-155.
15. Cutrera R.A., et al. Phase-shifting effect of 8-OH-DPAT, a 5-HT1A/5-HT7 receptor agonist, on locomotor activity in golden hamster in constant darkness. Neurosci. Lett. 1996, 210:1-4.
16. Dowling G.A., et al. Light treatment for neuropsychiatric behaviors in Alzheimer's disease. West. J. Nurs. Res. 2007, 29:961-975.
17. Eastman C.I., et al. Phase-shifting human circadian rhythms with exercise during the night shift. Physiol. Behav. 1995, 58:1287-1291.
18. Edgar D.M., Dement W.C. Regularly scheduled voluntary exercise synchronizes the mouse circadian clock. Am. J. Physiol. 1991, 261:R928-R933.
19. Fisher S.P., et al. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease. Brain 2013, 136:2159-2172.
20. Harrison D.J., et al. Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model. Exp. Neurol. 2013, 248:457-469.
21. Hockly E., et al. Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann. Neurol. 2002, 51:235-242.
22. Jacobs B.L., Fornal C.A. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 1999, 21:9S-15S.
23. Jicha G.A., Carr S.A. Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. J. Alzheimers Dis. 2010, 19:253-272.
24. Kantor S., et al. Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation. Brain 2013, 136:2147-2158.
25. Klein K.E., Wegmann H.M. The resynchronization of human circadian rhythms after transmeridian flights as a result of flight direction and mode of activity. Chronobiology 1974, 564-570. Igaku Shoin LTD, Tokyo. L.E. Scheving (Ed.).
26. Klein G.A., et al. Suprachiasmatic Nucleus. The Mind's Clock 1991, Oxford UP, New York.
27. Kudo T., et al. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease. Exp. Neurol. 2011, 228:80-90.
28. Lamont E.W., et al. Circadian rhythms and clock genes in psychotic disorders. Isr. J. Psychiatry Relat. Sci. 2010, 47:27-35.
29. Lione L.A., et al. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. 1999, 19:10428-10437.
30. Marchant E.G., Mistlberger R.E. Entrainment and phase shifting of circadian rhythms in mice by forced treadmill running. Physiol. Behav. 1996, 60:657-663.
31. Maywood E.S., et al. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. J. Neurosci. 2010, 30:10199-10204.
32. Meyer-Bernstein E.L., Morin L.P. Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J. Neurosci. 1996, 16:2097-2111.
33. Mistlberger R.E. Food-anticipatory circadian rhythms: concepts and methods. Eur. J. Neurosci. 2009, 30:1718-1729.
34. Mistlberger R.E., Skene D.J. Nonphotic entrainment in humans?. J. Biol. Rhythms 2005, 20:339-352.
35. Moore R.Y., Silver R. Suprachiasmatic nucleus organization. Chronobiol. Int. 1998, 15:475-487.
36. Morin L.P., Allen C.N. The circadian visual system, 2005. Brain Res. Rev. 2006, 51:1-60.
37. Morton A.J. Circadian and sleep disorder in Huntington's disease. Exp. Neurol. 2013, 243:34-44.
38. Morton A.J., et al. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J. Neurosci. 2005, 25:157-163.
39. Oakeshott S., et al. Circadian abnormalities in motor activity in a BAC transgenic mouse model of Huntington's disease. PLoS Curr. 2011, 3:RRN1225.
40. O'Gorman D.J., Krook A. Exercise and the treatment of diabetes and obesity. Med. Clin. North Am. 2011, 95:953-969.
41. Pail G., et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology 2011, 64:152-162.
42. Pallier P.N., et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J. Neurosci. 2007, 27:7869-7878.
43. Pang T.Y.C., et al. Differential effects of voluntary exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 2006, 141:569-584.
44. Paus S., et al. Bright light therapy in Parkinson's disease: a pilot study. Mov. Disord. 2007, 22:1495-1498.
45. Petersen A., Bjorkqvist M. Hypothalamic-endocrine aspects in Huntington's disease. Eur. J. Neurosci. 2006, 24:961-967.
46. Potter M.C., et al. Exercise is not beneficial and may accelerate symptom onset in a mouse model of Huntington's disease. PLoS Curr. 2010, 2:RRN1201.
47. Renoir T., et al. Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise. Br. J. Pharmacol. 2012, 165:1375-1389.
48. Ross C.A., Tabrizi S.J. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011, 10:83-98.
49. Schapira A.H., Jenner P. Etiology and pathogenesis of Parkinson's disease. Mov. Disord. 2011, 26:1049-1055.
50. Shiota M., et al. Using outdoor exercise to decrease jet lag in airline crewmembers. Aviat. Space Environ. Med. 1996, 67:1155-1160.
51. Siddiqui N.I., et al. Regular physical exercise: way to healthy life. Mymensingh Med. J. 2010, 19:154-158.
52. van Dellen A., et al. Delaying the onset of Huntington's in mice. Nature 2000, 404:721-722.
53. van Dellen A., et al. Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease. BMC Neurosci. 2008, 1:9-34.
54. Verwey M., Amir S. Food-entrainable circadian oscillators in the brain. Eur. J. Neurosci. 2009, 30:1650-1657.
55. Webb I.C., et al. Circadian clock resetting by behavioral arousal: neural correlates in the midbrain raphe nuclei and locus coeruleus. Neuroscience 2010, 166:739-751.
56. Whyte J.J., Laughlin M.H. The effects of acute and chronic exercise on the vasculature. Acta Physiol. (Oxf.) 2010, 199:441-450.
57. Willis G.L., Turner E.J. Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int. 2007, 24:521-537.
58. Wood N.I., et al. "Brain training" improves cognitive performance and survival in transgenic mouse model of Huntington's disease. Neurobiol. Dis. 2011, 42:427-437.
59. Wood N.I., et al. Adaptation to experimental jet-lag in R6/2 mice despite circadian dysrhythmia. PLoS One 2013, 8:e55036.